In conclusion, we are the first to report that quercetin is the active compound of CR that acts against MDD by targeting PAI-1 to enhance the liver response to LPS and glucose metabolism, which may shed light on the modern pharmacological mechanism of CR against MDD through soothing the liver. Here, SERPINE1 is linked to major depressive disorder.